Casdin Capital’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $4.14M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $6.58M | Hold |
|
|||||
|
2021
Q1 | $6.89M | Sell |
|
|||||
|
2020
Q4 | $16.9M | Hold |
|
|||||
|
2020
Q3 | $10.2M | Sell |
|
|||||
|
2020
Q2 | $13M | Hold |
|
|||||
|
2020
Q1 | $9.27M | Hold |
|
|||||
|
2019
Q4 | $12.2M | Hold |
|
|||||
|
2019
Q3 | $13.2M | Sell |
|
|||||
|
2019
Q2 | $16.5M | Buy |
|
|||||
|
2019
Q1 | $10.3M | Hold |
|
|||||
|
2018
Q4 | $12.4M | Sell |
|
|||||
|
2018
Q3 | $33.9M | Buy |
|
|||||
|
2018
Q2 | $19.9M | Hold |
|
|||||
|
2018
Q1 | $26.6M | Hold |
|
|||||
|
2017
Q4 | $23M | Hold |
|
|||||
|
2017
Q3 | $21M | Hold |
|
|||||
|
2017
Q2 | $12.3M | Buy |
|
|||||
|
2017
Q1 | $4.42M | Buy |
|